Clinical Trial Details
EORTC-24061
Back to Clinical Trials Database
Randomized phase II feasibility study of Cetuximab combined with 4 cycles of TPF followed by platinum based chemo-radiation strategies
Trial Status | All trial activities ended |
---|---|
Dates |
Date of activation: 11-Feb-2008 Date Step1 close: 17-May-2010 Date Step2 close: 17-May-2010 |
Data management at EORTC | Yes |
Design |
Phase 2 Randomized open label |
Targeted Sample size | All Groups: 55 |
Treatment | |
Study Staff | |
Type of cancer | |
Participating groups | |
Protocol summary | http://clinicaltrials.gov/study/NCT00646659 |
NCT number | NCT00646659 |
EudraCT | 2006-004189-14 |